Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Partners
More
CME/CE
Resources
Digital SupplementsInteractive ToolsLive EventsPress ReleasePublicationsSponsored
Advisory Board

Subscribe

  • News
  • Watch
  • Conferences
  • Partners
  • CME/CE
  • Resources
  • Advisory Board
  • Subscribe
  • Allergy
    • Seasonal Allergy
    • Food Allergy
    • Anaphylaxis
  • Biosimilars
  • Cardiology
    • Dyslipidemia
    • Arrhythmia
    • Cardiomyopathy
    • Structural Heart Disease
    • Atherosclerotic Cardiovascular Disease
    • Heart Failure
    • Hypertension
    • Stroke
  • Dermatology
    • Alopecia
    • Vitiligo
    • Hidradenitis Suppurativa
    • Acne
    • Atopic Dermatitis
    • Urticaria
    • Plaque Psoriasis
  • Endocrinology
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Polycystic Ovary Syndrome
    • Hormonal Disorders
    • Thyroid Disorders
  • FDA News
  • Family Medicine
    • Influenza
    • Vaccination
  • Gastroenterology
    • Exocrine Pancreatic Insufficiency
    • Inflammatory Bowel Disease
    • Eosinophilic Esophagitis
    • C Difficile Infection
    • Gastroesophageal Reflux Disease (GERD)
    • Irritable Bowel Syndrome
    • Peptic Ulcer
    • Ulcerative Colitis
  • Geriatrics
    • Dementia and Alzheimer Disease
    • Parkinson Disease
  • Hematology
    • Paroxysmal Nocturnal Hemoglobinuria
    • Anemia
    • Sickle Cell
  • Hepatology
    • Alpha-1 antitrypsin deficiency
    • Cholangitis
    • MASH / MASLD
    • Hepatitis C
  • Hospital Medicine
  • Infectious Disease
    • COVID-19
    • HIV/AIDS
  • Internal Medicine
  • Nephrology
    • C3 Glomerulopathy
    • IgA Nephropathy
    • Focal Segmental Glomerulosclerosis
    • Chronic Kidney Disease
  • Neurology
    • Epilepsy
    • Migraine
    • Tardive Dyskinesia
    • Traumatic Brain Injury
  • Obesity Management
  • Ophthalmology
    • Geographic Atrophy
    • Age-Related Macular Degeneration
    • Diabetic Macular Edema
    • Uveitis
  • Pain
    • Acute Pain
    • Chronic Pain
    • Multiple Sclerosis
    • Neuropathic Pain
  • Pediatrics
  • Psychiatry
    • PTSD
    • Addiction
    • ADHD
    • Bipolar Disorder
    • Major Depressive Disorder
    • Schizophrenia
  • Pulmonology
    • Lung Cancer
    • Pulmonary Fibrosis
    • Asthma
    • COPD
  • RDR Alert®
    • Vasculitis
    • Amyloidosis
    • Huntington Disease
    • Lysosomal Storage Disorders
  • Rheumatology
  • Sleep
    • Obstructive Sleep Apnea
    • Insomnia
  • Surgery
  • Women's Health
Spotlight -
FDA News|
This Year In Medicine 2025
Advertisement

Robert Bissonnette, MD

Advertisement
Robert Bissonnette, MD | Credit: International Psoriasis Council

Robert Bissonnette, MD, is the chairman at Innovaderm Research.

Articles by Robert Bissonnette, MD

Expert Perspectives: Dermatology's Top Story to Watch in 2025

Expert Perspectives: Dermatology's Top Story to Watch in 2025

BySusan Taylor, MD,Robert Bissonnette, MD,Robert Snyder, MD,Nada Elbuluk, MD, MSc,Lindsay S. Ackerman, MD, FAAD,Melinda Gooderham, MD,Christopher G. Bunick, MD, PhD,John Barbieri, MD, MBA,Brian Kim, MD
March 12th 2025

A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.

Robert Bissonnette, MD | Credit: International Psoriasis Council

Icotrokinra, Plaque Psoriasis, and ICONIC-LEAD, with Robert Bissonnette, MD

ByRobert Bissonnette, MD
March 8th 2025

Robert Bissonnette, MD, discusses data from the ICONIC-LEAD trial and the potential role of icotrokinra in plaque psoriasis.

Advertisement

Latest Updated Articles

  • Expert Perspectives: Dermatology's Top Story to Watch in 2025
    Expert Perspectives: Dermatology's Top Story to Watch in 2025

    March 12th 2025

  • Robert Bissonnette, MD | Credit: International Psoriasis Council
    Icotrokinra, Plaque Psoriasis, and ICONIC-LEAD, with Robert Bissonnette, MD

    March 8th 2025



Advertisement
Advertisement

Trending on HCPLive

1

Real-World Resmetirom Data Show Liver Stiffness Gains in MASH

2

IDEAL: Seladelpar Achieves ALP Normalization in Second-Line PBC

3

ELSPIRE: Elafibranor Achieves ALP Normalization in 85% With PBC

4

Oral STAT6 Degrader KT-621 Reduces EASI by 62.6% in Atopic Dermatitis

5

Moving the Needle in Medicine: Mentorship, Teams, and Heart Failure Leadership, With Robert Mentz, MD

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us